Uterine Leiomyoma (Uterine Fibroids) Ongoing Global Clinical Trials Analysis and Outlook

June 2018 | 94 pages | ID: UD54E073EBBEN
VPAResearch

Abstracts

Uterine Leiomyoma (Uterine Fibroids) ongoing clinical trials report from VPA Research provides comprehensive analysis and trends in global Uterine Leiomyoma (Uterine Fibroids) disease clinical trials. The research work analyzes the ongoing Uterine Leiomyoma (Uterine Fibroids) clinical trial trends across countries and companies.

The report focuses on drugs and therapies being evaluated for Uterine Leiomyoma (Uterine Fibroids) treatment in active clinical development phases including phase 1, phase 2, phase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, enrollment, phases, trial status and sponsor types.

Our experienced database team dynamically updates the clinical trials data from several sources including Clinical trial registries, conferences, journals and company releases etc. Further, data is presented in user friendly manner to enable readers quick access to Uterine Leiomyoma (Uterine Fibroids) clinical trials.

Scope of the Report-

• Ongoing Uterine Leiomyoma (Uterine Fibroids) clinical trials across regions
• Trial information by Phase and Subjects recruited
• Trial information by status, type, sponsor type
• Drugs used for treatment of Uterine Leiomyoma (Uterine Fibroids)
• Both observational and interventional trials analyzed
• Leading companies and universities participating in Uterine Leiomyoma (Uterine Fibroids) clinical trials

Reasons to Buy

• Track competition and design competitive advantages
• Identify right partners to associate with for further research
• Evaluate potential opportunities available in further clinical trials of the disease
• Formulate business development strategies through success rates of clinical trials
• Identify quick markets for recruiting subjects based on trials count by each market

Contents

1 TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2 KEY FINDINGS, 2018

2.1 Snapshot
2.2 Overview of Uterine Leiomyoma (Uterine Fibroids) Trials

3 CLINICAL TRIALS TRENDS TO 2022

3.1 Ongoing Uterine Leiomyoma (Uterine Fibroids) Trials by Phase
3.2 Ongoing Uterine Leiomyoma (Uterine Fibroids) Trials by Type
3.3 Ongoing Uterine Leiomyoma (Uterine Fibroids) Trials by Recruitment Status

4 COUNTRY LEVEL ANALYSIS

4.1 Region wise Ongoing Uterine Leiomyoma (Uterine Fibroids) Trials
4.2 Top 10 Countries conducting Uterine Leiomyoma (Uterine Fibroids) Trials
4.3 Trials in Emerging and Developing Economies

5 COMPANY LEVEL ANALYSIS

5.1 Ongoing Uterine Leiomyoma (Uterine Fibroids) Trials by Sponsor Type
5.2 Uterine Leiomyoma (Uterine Fibroids) Subjects by Sponsor Type
5.3 Subjects Recruited by Leading Sponsors

6 ENROLMENT TRENDS TO 2022

6.1 Subjects Recruited for Uterine Leiomyoma (Uterine Fibroids) Trials by year
6.2 Subjects Recruited for Uterine Leiomyoma (Uterine Fibroids) Trials by Phase
6.3 Subjects Recruited for Uterine Leiomyoma (Uterine Fibroids) Trials by Trial Type
6.4 Subjects Recruited for Uterine Leiomyoma (Uterine Fibroids) Trials by Recruitment Status

7 ONGOING TRIALS- PHASE, ID, TITLE, LOCATION, TYPE, DURATION, RECRUITMENT STATUS, COMPANY DETAILS

7.1 Ongoing Uterine Leiomyoma (Uterine Fibroids) Trials- Phase
7.2 Ongoing Uterine Leiomyoma (Uterine Fibroids) Trials- Phase
7.3 Ongoing Uterine Leiomyoma (Uterine Fibroids) Trials- Phase
7.4 Ongoing Uterine Leiomyoma (Uterine Fibroids) Trials- Phase

8 APPENDIX

8.1 Abbreviations and Definitions
8.2 Sources and Research Methodology

List Of Figures

LIST OF FIGURES

Figure 1: Uterine Leiomyoma (Uterine Fibroids)- Clinical Trials by Country
Figure 2: Uterine Leiomyoma (Uterine Fibroids)- Clinical Trials by Phase of Development, 2018
Figure 3: Uterine Leiomyoma (Uterine Fibroids)- Clinical Trials by Status, 2018
Figure 4: Uterine Leiomyoma (Uterine Fibroids)- Clinical Trials by Type, 2018
Figure 5: Uterine Leiomyoma (Uterine Fibroids)- Clinical Trials Split by Region, 2000-2018
Figure 6: Uterine Leiomyoma (Uterine Fibroids)- Clinical Trials by Type of Economy, 2018
Figure 7: Uterine Leiomyoma (Uterine Fibroids)- Enrolment by Phase, 2018
Figure 8: Uterine Leiomyoma (Uterine Fibroids)- Enrolment by Trial Type, 2018
Figure 9: Uterine Leiomyoma (Uterine Fibroids)- Enrolment by Recruitment Status, 2018
Figure 10: Uterine Leiomyoma (Uterine Fibroids)- Clinical Trials by Sponsor Type, 2018
Figure 11: Uterine Leiomyoma (Uterine Fibroids)- Enrolment by Type of Sponsors
Figure 12: Uterine Leiomyoma (Uterine Fibroids)- Enrolment by Leading Sponsors

List Of Tables

LIST OF TABLES

Table 1: Uterine Leiomyoma (Uterine Fibroids)- Clinical Trials by Sponsor Type, 2018
Table 2: Uterine Leiomyoma (Uterine Fibroids)- Clinical Trials by Economy Type, 2018
Table 3: Uterine Leiomyoma (Uterine Fibroids)- Clinical Trials by Region, 2018
Table 4: Uterine Leiomyoma (Uterine Fibroids)- Clinical Trial Participations of Top 10 Countries, 2018
Table 5: Uterine Leiomyoma (Uterine Fibroids)- Clinical Trials in Emerging and Developing Economies, 2018
Table 6: Uterine Leiomyoma (Uterine Fibroids)- Ongoing Phase 1 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 7: Uterine Leiomyoma (Uterine Fibroids)- Ongoing Phase 2 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 8: Uterine Leiomyoma (Uterine Fibroids)- Ongoing Phase 3 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 9: Uterine Leiomyoma (Uterine Fibroids)- Ongoing Phase 4 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company